302 related articles for article (PubMed ID: 18174313)
21. Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo.
Landriscina M; Bagalà C; Piscazzi A; Schinzari G; Quirino M; Fabiano A; Bianchetti S; Cassano A; Sica G; Barone C
Prostate; 2009 May; 69(7):744-54. PubMed ID: 19152342
[TBL] [Abstract][Full Text] [Related]
22. The deregulation of miR-17/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells.
Dankert JT; Wiesehöfer M; Czyrnik ED; Singer BB; von Ostau N; Wennemuth G
PLoS One; 2018; 13(7):e0200472. PubMed ID: 30001402
[TBL] [Abstract][Full Text] [Related]
23. The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression.
Long MD; Singh PK; Russell JR; Llimos G; Rosario S; Rizvi A; van den Berg PR; Kirk J; Sucheston-Campbell LE; Smiraglia DJ; Campbell MJ
Oncogene; 2019 Jan; 38(3):421-444. PubMed ID: 30120411
[TBL] [Abstract][Full Text] [Related]
24. Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles.
Tamura K; Furihata M; Tsunoda T; Ashida S; Takata R; Obara W; Yoshioka H; Daigo Y; Nasu Y; Kumon H; Konaka H; Namiki M; Tozawa K; Kohri K; Tanji N; Yokoyama M; Shimazui T; Akaza H; Mizutani Y; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
Cancer Res; 2007 Jun; 67(11):5117-25. PubMed ID: 17545589
[TBL] [Abstract][Full Text] [Related]
25. MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression.
Fujita Y; Kojima K; Ohhashi R; Hamada N; Nozawa Y; Kitamoto A; Sato A; Kondo S; Kojima T; Deguchi T; Ito M
J Biol Chem; 2010 Jun; 285(25):19076-84. PubMed ID: 20406806
[TBL] [Abstract][Full Text] [Related]
26. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth.
Nadiminty N; Tummala R; Lou W; Zhu Y; Shi XB; Zou JX; Chen H; Zhang J; Chen X; Luo J; deVere White RW; Kung HJ; Evans CP; Gao AC
PLoS One; 2012; 7(3):e32832. PubMed ID: 22479342
[TBL] [Abstract][Full Text] [Related]
28. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
29. Androgen-stimulated UDP-glucose dehydrogenase expression limits prostate androgen availability without impacting hyaluronan levels.
Wei Q; Galbenus R; Raza A; Cerny RL; Simpson MA
Cancer Res; 2009 Mar; 69(6):2332-9. PubMed ID: 19244115
[TBL] [Abstract][Full Text] [Related]
30. Endothelin-1 production by prostate cancer cell lines is up-regulated by factors involved in cancer progression and down-regulated by androgens.
Granchi S; Brocchi S; Bonaccorsi L; Baldi E; Vinci MC; Forti G; Serio M; Maggi M
Prostate; 2001 Dec; 49(4):267-77. PubMed ID: 11746273
[TBL] [Abstract][Full Text] [Related]
31. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
[TBL] [Abstract][Full Text] [Related]
32. EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR).
Bonaccorsi L; Carloni V; Muratori M; Formigli L; Zecchi S; Forti G; Baldi E
Int J Cancer; 2004 Oct; 112(1):78-86. PubMed ID: 15305378
[TBL] [Abstract][Full Text] [Related]
33. Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.
Tepper CG; Gregg JP; Shi XB; Vinall RL; Baron CA; Ryan PE; Desprez PY; Kung HJ; deVere White RW
Prostate; 2005 Dec; 65(4):375-89. PubMed ID: 16037992
[TBL] [Abstract][Full Text] [Related]
34. Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis.
Zhang Y; Zhao J; Ding M; Su Y; Cui D; Jiang C; Zhao S; Jia G; Wang X; Ruan Y; Jing Y; Xia S; Han B
J Exp Clin Cancer Res; 2020 Dec; 39(1):282. PubMed ID: 33317606
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
36. microRNA-148a-3p enhances the effects of sevoflurane on hepatocellular carcinoma cell progression via ROCK1 repression.
Sun Y; Liu L; Xing W; Sun H
Cell Signal; 2021 Jul; 83():109982. PubMed ID: 33741494
[TBL] [Abstract][Full Text] [Related]
37. Up-regulated microRNA-143 in cancer stem cells differentiation promotes prostate cancer cells metastasis by modulating FNDC3B expression.
Fan X; Chen X; Deng W; Zhong G; Cai Q; Lin T
BMC Cancer; 2013 Feb; 13():61. PubMed ID: 23383988
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of miR-200b-3p by low p73 contributes to the androgen-independence of prostate cancer cells.
He M; Liu Y; Deng X; Qi S; Sun X; Liu G; Liu Y; Liu Y; Zhao M
Prostate; 2013 Jul; 73(10):1048-56. PubMed ID: 23389960
[TBL] [Abstract][Full Text] [Related]
39. Molecular regulation of androgen action in prostate cancer.
Dehm SM; Tindall DJ
J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832
[TBL] [Abstract][Full Text] [Related]
40. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.
Kikugawa T; Kinugasa Y; Shiraishi K; Nanba D; Nakashiro K; Tanji N; Yokoyama M; Higashiyama S
Prostate; 2006 Jul; 66(10):1092-9. PubMed ID: 16637071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
